Gesponsert
North America Duchenne Muscular Dystrophy (DMD) Treatment Market to Surpass USD 8.84 Billion by 2033, Fueled by 20.2% CAGR
The North America Duchenne Muscular Dystrophy (DMD) Treatment Market was valued at US$ 2.06 billion in 2024 and is projected to reach US$ 8.84 billion by 2033, growing at a remarkable CAGR of 20.2% from 2025 to 2033. DMD is a severe, progressive genetic disorder characterized by muscle weakness and degeneration, predominantly affecting young boys. Despite being rare, the high disease burden...
0 Kommentare 0 Geteilt 89 Ansichten 0 Bewertungen
Gesponsert
Gesponsert
Gesponsert